Prenatal dexamethasone use for the prevention of virilization in pregnancies at risk for classical congenital adrenal hyperplasia because of 21-hydroxylase (CYP21A2) deficiency: A systematic review and meta-analyses

Clinical Endocrinology

Volumn 73, Issue 4, 2010, Pages 436-444

  Merce Fernandez Balsells M ^a,b   Muthusamy, Kalpana ^a   Smushkin, Galina ^a   Lampropulos, Julianna F ^a   Elamin, Mohamed B ^a   Abu Elnour, Nisrin O ^a   Elamin, Khalid B ^c   Agrwal, Neera ^a,d   Gallegos Orozco, Juan F ^a   Lane, Melanie A ^a   Erwin, Patricia J ^a   Montori, Victor M ^a   Murad, M Hassan ^a  

^a MAYO CLINIC   (United States)

^b HOSPITAL JOSEP TRUETA   (Spain)

^c St Lukes General Hospital Kilkenny   (Ireland)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE;

ARTICLE; CLINICAL TRIAL; COCHRANE LIBRARY; CONGENITAL ADRENAL HYPERPLASIA; DRUG EFFECT; EDEMA; EMBASE; ENVIRONMENTAL EXPOSURE; FETUS MALFORMATION; FOLLOW UP; HUMAN; MEDLINE; META ANALYSIS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRENATAL PERIOD; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; SPONTANEOUS ABORTION; STEROID 21 MONOOXYGENASE DEFICIENCY; STILLBIRTH; STRIA; SYSTEMATIC REVIEW; VIRILIZATION;

ADRENAL HYPERPLASIA, CONGENITAL; DEXAMETHASONE; FEMALE; FETUS; HUMANS; PREGNANCY; RISK; VIRILISM;

EID: 77956568802     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2010.03826.x     Document Type: Article

References (22)

1. Clayton, P.E., Miller, W.L., Oberfield, S.E. et al. (2002) Consensus statement on 21-hydroxylase deficiency from the European Society for Paediatric Endocrinology and the Lawson Wilkins Pediatric Endocrine Society. Hormone Research, 58, 188 195.
2. Therrell, B.L. (2001) Newborn screening for congenital adrenal hyperplasia. Endocrinology and Metabolism Clinics of North America, 30, 15 30.
3. Forest, M.G. (2004) Recent advances in the diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Human Reproduction Update, 10, 469 485.
4. Speiser, P.W. White, P.C. (2003) Congenital adrenal hyperplasia. New England Journal of Medicine, 349, 776 788.
5. Finning, K.M. Chitty, L.S. (2008) Non-invasive fetal sex determination: impact on clinical practice. Seminars in Fetal & Neonatal Medicine, 13, 69 75.
6. Seckl, J.R. (2004) Prenatal glucocorticoids and long-term programming. European Journal of Endocrinology, 151 (Suppl 3 U49 U62.
7. Moher, D., Liberati, A., Tetzlaff, J. et al. (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Medicine/Public Library of Science, 6, e1000097.
8. Swiglo, B.A., Murad, M.H., Schunemann, H.J. et al. (2008) A case for clarity, consistency, and helpfulness: state-of-the-art clinical practice guidelines in endocrinology using the grading of recommendations, assessment, development, and evaluation system. Journal of Clinical Endocrinology & Metabolism, 93, 666 673.
9. DerSimonian, R. Laird, N. (1986) Meta-analysis in clinical trials. Controlled Clinical Trials, 7, 177 188.
10. Higgins, J.P.T. Thompson, S.G. (2002) Quantifying heterogeneity in a meta-analysis. Statistics in Medicine, 21, 1539 1558.
11. Lajic, S., Wedell, A., Bui, T.H. et al. (1998) Long-term somatic follow-up of prenatally treated children with congenital adrenal hyperplasia. Journal of Clinical Endocrinology & Metabolism, 83, 3872 3880.
12. Mercado, A.B., Wilson, R.C., Cheng, K.C. et al. (1995) Prenatal treatment and diagnosis of congenital adrenal hyperplasia owing to steroid 21-hydroxylase deficiency. Journal of Clinical Endocrinology & Metabolism, 80, 2014 2020.
13. New, M.I., Carlson, A., Obeid, J. et al. (2001) Prenatal diagnosis for congenital adrenal hyperplasia in 532 pregnancies. Journal of Clinical Endocrinology & Metabolism, 6, 5651 5657.
14. New, M., Carlson, A., Obeid, J. et al. (2003) Update: Prenatal Diagnosis for Congenital Adrenal Hyperplasia in 595 Pregnancies. Endocrinologist, 13, 233 239.
15. Trautman, P.D., Meyer-Bahlburg, H.F., Postelnek, J. et al. (1995) Effects of early prenatal dexamethasone on the cognitive and behavioral development of young children: results of a pilot study. Psychoneuroendocrinology, 20, 439 449.
16. Meyer-Bahlburg, H.F.L., Dolezal, C., Baker, S.W. et al. (2004) Cognitive and motor development of children with and without congenital adrenal hyperplasia after early-prenatal dexamethasone. Journal of Clinical Endocrinology & Metabolism, 89, 610 614.
17. Hirvikoski, T., Nordenstrom, A., Lindholm, T. et al. (2008) Long-term follow-up of prenatally treated children at risk for congenital adrenal hyperplasia: does dexamethasone cause behavioural problems? European Journal of Endocrinology, 159, 309 316.
18. Hirvikoski, T., Nordenstrom, A., Lindholm, T. et al. (2007) Cognitive functions in children at risk for congenital adrenal hyperplasia treated prenatally with dexamethasone. Journal of Clinical Endocrinology & Metabolism, 92, 542 548.
19. Prader, A. (1954) [Genital findings in the female pseudo-hermaphroditism of the congenital adrenogenital syndrome; morphology, frequency, development and heredity of the different genital forms.]. Helvetica Paediatrica Acta, 9, 231 248.
20. Meyer-Bahlburg, H.F. (1999) What causes low rates of child-bearing in congenital adrenal hyperplasia? Journal of Clinical Endocrinology & Metabolism, 84, 1844 1847.
21. Meyer-Bahlburg, H.F. (2001) Gender and sexuality in classic congenital adrenal hyperplasia. Endocrinology & Metabolism Clinics of North America, 30, 155 171.
22. Joint Lawson Wilkins Pediatric Endocrine Society/European Society for Pediatric Endocrinology CAH Working Group 2002) Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. Journal of Clinical Endocrinology and Metabolism, 87, 4048 4053.